Nutromics

medical devices

About

Nutromics is an Australian healthcare technology company founded in 2017, focused on revolutionizing healthcare through Continuous Molecular Monitoring (CMM). Headquartered in Melbourne, with an R&D facility in San Diego, the company employs over 50 people and has raised around USD 30 million in funding. Nutromics aims to achieve zero preventable deaths by providing personalized and timely molecular insights. The company has developed a pioneering medical wearable device, a patch that combines a microneedle array and DNA-based sensor technology. This "lab-on-a-patch®" allows for continuous, real-time molecular monitoring by converting molecular signals into electrical signals that are transmitted via Bluetooth to clinicians. Nutromics is currently working on a continuous monitor for the intravenous antibiotic vancomycin, with plans for FDA approval in 2025, and is advancing a pipeline of new DNA sensors for various clinical applications. Their technology is designed to enhance patient outcomes and reduce healthcare costs by enabling dynamic monitoring of conditions that require trend data for effective treatment.

Technologies

Mailchimp Mandrill Outlook MailChimp SPF Amazon AWS Microsoft Office 365 Mobile Friendly Google Tag Manager Google Font API Remote AI

Keywords

microneedles wearables aptamers biosensors medtech medical devices diagnostics medical equipment manufacturing b2b biomedical research wearable biosensor sensor technology lab-on-a-patch dna-based biosensors biotech research collaborations medical diagnostics healthcare innovation biosensor clinical validation proactive health monitoring health monitoring system healthcare industry biosensing for chronic conditions medical technology drug monitoring sensor integration biotech research real-time health data healthcare providers electrochemical aptamer sensors diagnostic device

Location

420 Victoria St, Melbourne, Victoria, Australia, 3051

Related Companies

Companies in the same industry